000 | 01844 a2200541 4500 | ||
---|---|---|---|
005 | 20250518001157.0 | ||
264 | 0 | _c20200406 | |
008 | 202004s 0 0 eng d | ||
022 | _a1097-4644 | ||
024 | 7 |
_a10.1002/jcb.27714 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aWen, Yi | |
245 | 0 | 0 |
_aArtemisinin attenuates tubulointerstitial inflammation and fibrosis via the NF-κB/NLRP3 pathway in rats with 5/6 subtotal nephrectomy. _h[electronic resource] |
260 |
_bJournal of cellular biochemistry _c03 2019 |
||
300 |
_a4291-4300 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAnti-Inflammatory Agents _xpharmacology |
650 | 0 | 4 |
_aArtemisia _xchemistry |
650 | 0 | 4 |
_aArtemisinins _xpharmacology |
650 | 0 | 4 | _aCell Line |
650 | 0 | 4 |
_aEpithelial Cells _xdrug effects |
650 | 0 | 4 | _aFibrosis |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aInflammasomes _xdrug effects |
650 | 0 | 4 |
_aKidney _xcytology |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aNF-kappa B _xmetabolism |
650 | 0 | 4 |
_aNLR Family, Pyrin Domain-Containing 3 Protein _xmetabolism |
650 | 0 | 4 |
_aNephrectomy _xadverse effects |
650 | 0 | 4 |
_aNephritis, Interstitial _xdrug therapy |
650 | 0 | 4 |
_aPlant Extracts _xtherapeutic use |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Sprague-Dawley |
650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
700 | 1 | _aPan, Ming-Ming | |
700 | 1 | _aLv, Lin-Li | |
700 | 1 | _aTang, Tao-Tao | |
700 | 1 | _aZhou, Le-Ting | |
700 | 1 | _aWang, Bin | |
700 | 1 | _aLiu, Hong | |
700 | 1 | _aWang, Feng-Mei | |
700 | 1 | _aMa, Kun-Ling | |
700 | 1 | _aTang, Ri-Ning | |
700 | 1 | _aLiu, Bi-Cheng | |
773 | 0 |
_tJournal of cellular biochemistry _gvol. 120 _gno. 3 _gp. 4291-4300 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1002/jcb.27714 _zAvailable from publisher's website |
999 |
_c28879154 _d28879154 |